Ilakkiya

Ilakkiya is a computational drug discovery company based in Cambridge, Massachusetts, focused on leveraging machine learning and molecular simulation to design novel small molecule therapeutics. The company was founded by industry veterans Pat Walters and Lakshmi Akella, who previously held leadership roles at Relay Therapeutics. Ilakkiya's platform integrates high-fidelity physics-based modeling with advanced AI to address challenging biological targets that are often considered undruggable. By streamlining the transition from target identification to lead optimization, the company aims to accelerate the delivery of high-quality clinical candidates. Ilakkiya operates at the intersection of data science and structural biology to enhance the precision of drug design.